News | News By Subject | News by Disease News By Date | Search News

Constipation News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Valeant (VRX), Progenics (PGNX) Shares Climb on Constipation Drug Approval     7/20/2016
FDA Extends Action Date for Progenics (PGNX), Valeant (VRX)'s NDA for Oral RELISTOR     4/4/2016
AstraZeneca PLC (AZN) Continues to Unload the Excess Fat with $70 Million Moventig Deal     3/1/2016
Synthetic Biologics (SYN)'s IBS-C Drug Meets All Endpoints in Second Phase II Study     1/20/2016
AstraZeneca PLC (AZN), Daiichi Sankyo in $825 Million Drug Tie-Up     3/19/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Sucampo Pharmaceuticals, Inc. (SCMP), Takeda Pharmaceutical Co. Ltd. (TKPYY)'s New Drug Application For AMITIZA® Dealt A Huge Setback     3/17/2014
AstraZeneca PLC (AZN), Nektar Therapeutics (CA) (NKTR) Hedge Bets on Constipation Drug     8/12/2013
Sucampo Pharmaceuticals, Inc. (SCMP) Wins Approval for Expanded Use of Amitiza in U.S.     4/23/2013
AstraZeneca PLC (AZN) Ready to File Constipation Drug Naloxegol     2/27/2013
Synergy Pharmaceuticals' Constipation Drug Meets Study Goals     1/2/2013
AstraZeneca PLC (AZN), Nektar Therapeutics (CA) (NKTR) Opioid Constipation Drug May Have Failed Phase III Study     11/14/2012
Positive Results for AstraZeneca PLC (AZN)'s Constipation Treatment     11/12/2012

News from Around the Web
Acupuncture With A Zap May Ease Constipation, China Academy Of Chinese Medical Sciences Study     9/13/2016
Constipated? Study Finds Surprising Cause, Yale University Reveals     6/9/2016
Doctors Find 11 Pounds Of Poop in Man Who Allegedly Didn't Go For 10 Years     9/3/2015
Suffering From Constipation? Self-Acupressure Can Help, University of California, Los Angeles (UCLA) Study     11/26/2014
The Safety of Daily Magnesium Oxide Treatment for Children with Chronic Constipation, Gunma University Graduate School of Medicine Study     3/8/2011
Plugged Up: Doctors See Signs of Worsening Constipation in Children, Johns Hopkins Children's Center Study     10/28/2010
OTC Drug Better for Constipation Claims Northern General Hospital     7/9/2010
Two Drugs Show Promise Against Severe Constipation; Help Chronic Cases, Terminally Ill Patients On Opiod Painkillers, Mayo Clinic Study     5/29/2008
MiraLax Safe for Chronic Constipation     7/25/2007
Medicines Made From Cow Urine And Dung     3/2/2005
World's Biggest Study Of Multi-Million Pound Health Problem Launched     2/22/2005

Press Releases
Ardelyx (ARDX) Reports Successful Phase III T3MPO-1 Trial Of Tenapanor In Patients With IBS-C     5/12/2017
Synergy Pharma (SGYP) Presents New Insights At Digestive Disease Week (DDW) Examining Patient And Physician Perceptions And Experiences With Chronic Idiopathic Constipation (CIC)     5/8/2017
Synergy Pharma (SGYP) To Present TRULANCE (Plecanatide) Phase III Data At Digestive Disease Week (DDW) For The Treatment Of Adults With Chronic Idiopathic Constipation (CIC) With Moderate To Very Severe Bloating     5/8/2017
Synergy Pharma (SGYP) Submits Supplemental New Drug Application (sNDA) For TRULANCE (Plecanatide) For The Treatment Of Adults With Irritable Bowel Syndrome With Constipation (IBS-C)     3/27/2017
Shionogi Release: FDA Approves Symproic (Naldemedine) Once-Daily Tablets C-II For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-Cancer Pain     3/24/2017
Albireo (ALBO) Announces Submission Of New Drug Application For Elobixibat In Japan     2/1/2017
Allergan (AGN) Release: FDA Approves 72 Mcg Dose Of LINZESS (Linaclotide) For Adults With Chronic Idiopathic Constipation     1/26/2017
Synergy Pharma (SGYP) Release: TRULANCE (Plecanatide) Receives U.S. FDA Approval For The Treatment Of Adults With Chronic Idiopathic Constipation     1/20/2017
Synergy Pharma Presents Long-Term Data For Plecanatide In Chronic Idiopathic Constipation At The American College of Gastroenterology Annual Scientific Meeting     10/17/2016
Boston's Albireo Reports Positive Late Stage Data Results for Elobixibat     10/3/2016
Shionogi Release: Naldemedine Phase III Study Demonstrates Long-Term Safety And Efficacy For The Treatment Of Opioid-Induced Constipation     9/7/2016
Valeant (VRX) And Progenics (PGNX) Announce The U.S. Commercial Launch Of FDA-Approved Relistor Tablets     9/7/2016
ColonaryConcepts Initiates Phase I Study Of New Approach To Treating Chronic Constipation     8/3/2016
Progenics (PGNX) Receives $50 Million Milestone Payment Following FDA Approval Of RELISTOR Tablets For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-Cancer Pain     7/26/2016
Ironwood (IRWD) And Allergan (AGN) Announce Supplemental New Drug Application For 72 Mcg Linaclotide In Chronic Idiopathic Constipation Has Been Accepted For FDA Review     6/9/2016